Cargando…
Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
Background Co-trimoxazole is an antibiotic combination used for the treatment of Pneumocystis jirovecii pneumonia, amongst others. Co-trimoxazole is known to increase serum potassium. For this reason, Dutch guidelines advise serum potassium monitoring in high-risk patients. Objective This study aime...
Autores principales: | Plantaz, Milan M. E. A., Veldman, Bart A. J., Esselink, Anne C., Fleuren, Hanneke W. H. A., Kramers, Cornelis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275024/ https://www.ncbi.nlm.nih.gov/pubmed/32390087 http://dx.doi.org/10.1007/s11096-020-01052-x |
Ejemplares similares
-
Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
por: Al AdAwi, Rana M, et al.
Publicado: (2021) -
Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia
por: van der Heijden, Charlotte D.C.C., et al.
Publicado: (2019) -
Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients
por: Khorvash, Farzin, et al.
Publicado: (2016) -
Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
por: Chowdhry, Vivek, et al.
Publicado: (2015) -
Evaluation of Weight-Based Co-trimoxazole Dosing in a Saudi Tertiary Hospital
por: Alshehri, Samah, et al.
Publicado: (2023)